Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 21, 2013 - Issue 1
Submit an article Journal homepage
347
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Comparison of Two Different Combination Immunosuppressive Therapies in the Treatment of Vogt-Koyonagi-Harada Syndrome

Cheryl A. Arcinue
, MD,
Alaa Radwan
, MD,
May O. LebananDepartment of Epidemiology and Biostatistics, College of Public Health, University of the Philippines, Manila, Philippines
, MSPH &
C. Stephen FosterCorrespondence[email protected]
, MD
Pages 47-52 | Received 26 Jun 2012, Accepted 06 Sep 2012, Published online: 16 Jan 2013

REFERENCES

  • Agarwal M, Ganesh SK, Biswas J. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome. Ocul Immunol Inflamm. 2006;14:333–339.
  • Paredes I, Ahmed M, Foster CS. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy. Ocul Immunol Inflamm. 2006;14:87–90.
  • Rao NA. Management of intraocular inflammation. In: Ryan SJ, ed. Retina, vol. 2. St. Louis, MO: Mosby; 2001:1032–1038.
  • Foster CS, Vitale AT. Immunosuppressive chemotherapy. In: FosterVitale. Diagnosis and Treatment of Uveitis. Philadelphia, PA: WB Saunders; 2002:177–214.
  • Cuchacovich M, Solanes F, Diaz G, et al. Comparison of the clinical efficacy of two different immunosuppressive regimens in patients with chronic Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2010;18:200–207.
  • Kim SJ, Yu HG. The use of low-dose azathioprine in patients with Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2007;15:381–387.
  • Snyder DA, Tessler HH. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1980;90:69–75.
  • Andreoli CM, Foster CS. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin. 2006;46:111–122.
  • Rao NA. Treatment of Vogt-Koyanagi-Harada disease by corticosteroids and immunosuppressive agents. Ocul Immunol Inflamm. 2006;14:71–72.
  • Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492–513.
  • Andrasch RH, Burns RP. Immunosuppressive therapy in severe chronic uveitis. Arch Ophthal. 1978;96:247–251.
  • Lau CH, Comer M, Lightman S. Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation. Clin Exp Ophthalmol. 2003;31:487–491.
  • Wider RL. Treatment of patients with rheumatoid arthritis refractory to standard therapy. JAMA. 1988;259:2446–2449.
  • Mourad G, et al. Triple agent immunosuppression (cyclosporine, azathioprine and low dose prednisolone) an effective regimen in first cadaver kidney transplantation. Transplant Proc. 1987;19:3672–3673.
  • Hooper PL, Kaplan HJ. Triple agent immunosuppression in serpiginous choroiditis. Ophthalmology. 1991;98:944–951.
  • Nussenblatt RB, Palestine AG, Chan CC. Cyclosporine therapy for uveitis: long-term followup. J Ocul Pharmacol. 1985;1:369–382.
  • Kaçmaz RO, Kempen JH, Newcomb C, et al. Cyclosporine for ocular inflammatory diseases. Ophthalmology. 2010;117:576–584.
  • Vitale AT, Rodriguez A, Foster CS. Low dose cyclosporine A therapy in treating chronic, noninfectious uveitis. Ophthalmology. 1996;103:365–374.
  • Liu X, Yang P, Lin X, et al. Inhibitory effect of cyclosporine A and corticosteroids on the production of IFN-γ and IL-17 by T cells in Vogt-Koyonagi-Harada syndrome. Clin Immunol. 2009;131:333–342.
  • Cho ML, Ju JH, Kim KW, et al. Cyclosporine A inhibits IL-15-induced IL-17 production in CD4+ T cells via down-regulation of PI3K/Akt and NF-kappaB. Immunol Lett. 2007;108:88–96.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.